• レポートコード:QY2207E01382 • 出版社/出版日:QYResearch / 2022年7月 • レポート形態:英文、PDF、91ページ • 納品方法:Eメール(納期:3日) • 産業分類:化学&材料 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のロイ-エンケファリンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にロイ-エンケファリンの世界市場のxxx%を占める「0.95」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国のロイ-エンケファリンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのロイ-エンケファリン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのロイ-エンケファリン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 ロイ-エンケファリンのグローバル主要メーカーには、Peptide Institute、Waters Corporation、Tocris Bioscience、Aapptec、Phoenix Pharmaceuticals、MediMabs、LifeTeinなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 ロイ-エンケファリン市場は、種類と用途によって区分されます。世界のロイ-エンケファリン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.95、0.99 【用途別セグメント】 科学研究、医療、その他 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - ロイ-エンケファリン製品概要 - 種類別市場(0.95、0.99) - 用途別市場(科学研究、医療、その他) - 調査の目的 ・エグゼクティブサマリー - 世界のロイ-エンケファリン販売量予測2017-2028 - 世界のロイ-エンケファリン売上予測2017-2028 - ロイ-エンケファリンの地域別販売量 - ロイ-エンケファリンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ロイ-エンケファリン販売量 - 主要メーカー別ロイ-エンケファリン売上 - 主要メーカー別ロイ-エンケファリン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(0.95、0.99) - ロイ-エンケファリンの種類別販売量 - ロイ-エンケファリンの種類別売上 - ロイ-エンケファリンの種類別価格 ・用途別市場規模(科学研究、医療、その他) - ロイ-エンケファリンの用途別販売量 - ロイ-エンケファリンの用途別売上 - ロイ-エンケファリンの用途別価格 ・北米市場 - 北米のロイ-エンケファリン市場規模(種類別、用途別) - 主要国別のロイ-エンケファリン市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパのロイ-エンケファリン市場規模(種類別、用途別) - 主要国別のロイ-エンケファリン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋のロイ-エンケファリン市場規模(種類別、用途別) - 主要国別のロイ-エンケファリン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米のロイ-エンケファリン市場規模(種類別、用途別) - 主要国別のロイ-エンケファリン市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカのロイ-エンケファリン市場規模(種類別、用途別) - 主要国別のロイ-エンケファリン市場規模(トルコ、サウジアラビア) ・企業情報 Peptide Institute、Waters Corporation、Tocris Bioscience、Aapptec、Phoenix Pharmaceuticals、MediMabs、LifeTein ・産業チェーン及び販売チャネル分析 - ロイ-エンケファリンの産業チェーン分析 - ロイ-エンケファリンの原材料 - ロイ-エンケファリンの生産プロセス - ロイ-エンケファリンの販売及びマーケティング - ロイ-エンケファリンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ロイ-エンケファリンの産業動向 - ロイ-エンケファリンのマーケットドライバー - ロイ-エンケファリンの課題 - ロイ-エンケファリンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Leu-Enkephalin Market
Due to the COVID-19 pandemic, the global Leu-Enkephalin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.95 accounting for % of the Leu-Enkephalin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Leu-Enkephalin market size is valued at US$ million in 2021, while the US and Europe Leu-Enkephalin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Leu-Enkephalin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Leu-Enkephalin include Peptide Institute, Waters Corporation, Tocris Bioscience, Aapptec, Phoenix Pharmaceuticals, MediMabs and LifeTein, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Leu-Enkephalin capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Leu-Enkephalin by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Global Leu-Enkephalin Scope and Segment
Leu-Enkephalin market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global Leu-Enkephalin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
0.95
0.99
Segment by Application
Scientific Research
Medical
Others
By Company
Peptide Institute
Waters Corporation
Tocris Bioscience
Aapptec
Phoenix Pharmaceuticals
MediMabs
LifeTein
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Leu-Enkephalin Product Introduction
1.2 Market by Purity
1.2.1 Global Leu-Enkephalin Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.95
1.2.3 0.99
1.3 Market by Application
1.3.1 Global Leu-Enkephalin Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Leu-Enkephalin Production
2.1 Global Leu-Enkephalin Production Capacity (2017-2028)
2.2 Global Leu-Enkephalin Production by Region: 2017 VS 2021 VS 2028
2.3 Global Leu-Enkephalin Production by Region
2.3.1 Global Leu-Enkephalin Historic Production by Region (2017-2022)
2.3.2 Global Leu-Enkephalin Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Leu-Enkephalin Sales in Volume & Value Estimates and Forecasts
3.1 Global Leu-Enkephalin Sales Estimates and Forecasts 2017-2028
3.2 Global Leu-Enkephalin Revenue Estimates and Forecasts 2017-2028
3.3 Global Leu-Enkephalin Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Leu-Enkephalin Sales by Region
3.4.1 Global Leu-Enkephalin Sales by Region (2017-2022)
3.4.2 Global Sales Leu-Enkephalin by Region (2023-2028)
3.5 Global Leu-Enkephalin Revenue by Region
3.5.1 Global Leu-Enkephalin Revenue by Region (2017-2022)
3.5.2 Global Leu-Enkephalin Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Leu-Enkephalin Production Capacity by Manufacturers
4.2 Global Leu-Enkephalin Sales by Manufacturers
4.2.1 Global Leu-Enkephalin Sales by Manufacturers (2017-2022)
4.2.2 Global Leu-Enkephalin Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Leu-Enkephalin in 2021
4.3 Global Leu-Enkephalin Revenue by Manufacturers
4.3.1 Global Leu-Enkephalin Revenue by Manufacturers (2017-2022)
4.3.2 Global Leu-Enkephalin Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Leu-Enkephalin Revenue in 2021
4.4 Global Leu-Enkephalin Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Leu-Enkephalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Leu-Enkephalin Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Leu-Enkephalin Sales by Purity
5.1.1 Global Leu-Enkephalin Historical Sales by Purity (2017-2022)
5.1.2 Global Leu-Enkephalin Forecasted Sales by Purity (2023-2028)
5.1.3 Global Leu-Enkephalin Sales Market Share by Purity (2017-2028)
5.2 Global Leu-Enkephalin Revenue by Purity
5.2.1 Global Leu-Enkephalin Historical Revenue by Purity (2017-2022)
5.2.2 Global Leu-Enkephalin Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
5.3 Global Leu-Enkephalin Price by Purity
5.3.1 Global Leu-Enkephalin Price by Purity (2017-2022)
5.3.2 Global Leu-Enkephalin Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Leu-Enkephalin Sales by Application
6.1.1 Global Leu-Enkephalin Historical Sales by Application (2017-2022)
6.1.2 Global Leu-Enkephalin Forecasted Sales by Application (2023-2028)
6.1.3 Global Leu-Enkephalin Sales Market Share by Application (2017-2028)
6.2 Global Leu-Enkephalin Revenue by Application
6.2.1 Global Leu-Enkephalin Historical Revenue by Application (2017-2022)
6.2.2 Global Leu-Enkephalin Forecasted Revenue by Application (2023-2028)
6.2.3 Global Leu-Enkephalin Revenue Market Share by Application (2017-2028)
6.3 Global Leu-Enkephalin Price by Application
6.3.1 Global Leu-Enkephalin Price by Application (2017-2022)
6.3.2 Global Leu-Enkephalin Price Forecast by Application (2023-2028)
7 North America
7.1 North America Leu-Enkephalin Market Size by Purity
7.1.1 North America Leu-Enkephalin Sales by Purity (2017-2028)
7.1.2 North America Leu-Enkephalin Revenue by Purity (2017-2028)
7.2 North America Leu-Enkephalin Market Size by Application
7.2.1 North America Leu-Enkephalin Sales by Application (2017-2028)
7.2.2 North America Leu-Enkephalin Revenue by Application (2017-2028)
7.3 North America Leu-Enkephalin Sales by Country
7.3.1 North America Leu-Enkephalin Sales by Country (2017-2028)
7.3.2 North America Leu-Enkephalin Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Leu-Enkephalin Market Size by Purity
8.1.1 Europe Leu-Enkephalin Sales by Purity (2017-2028)
8.1.2 Europe Leu-Enkephalin Revenue by Purity (2017-2028)
8.2 Europe Leu-Enkephalin Market Size by Application
8.2.1 Europe Leu-Enkephalin Sales by Application (2017-2028)
8.2.2 Europe Leu-Enkephalin Revenue by Application (2017-2028)
8.3 Europe Leu-Enkephalin Sales by Country
8.3.1 Europe Leu-Enkephalin Sales by Country (2017-2028)
8.3.2 Europe Leu-Enkephalin Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Leu-Enkephalin Market Size by Purity
9.1.1 Asia Pacific Leu-Enkephalin Sales by Purity (2017-2028)
9.1.2 Asia Pacific Leu-Enkephalin Revenue by Purity (2017-2028)
9.2 Asia Pacific Leu-Enkephalin Market Size by Application
9.2.1 Asia Pacific Leu-Enkephalin Sales by Application (2017-2028)
9.2.2 Asia Pacific Leu-Enkephalin Revenue by Application (2017-2028)
9.3 Asia Pacific Leu-Enkephalin Sales by Region
9.3.1 Asia Pacific Leu-Enkephalin Sales by Region (2017-2028)
9.3.2 Asia Pacific Leu-Enkephalin Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Leu-Enkephalin Market Size by Purity
10.1.1 Latin America Leu-Enkephalin Sales by Purity (2017-2028)
10.1.2 Latin America Leu-Enkephalin Revenue by Purity (2017-2028)
10.2 Latin America Leu-Enkephalin Market Size by Application
10.2.1 Latin America Leu-Enkephalin Sales by Application (2017-2028)
10.2.2 Latin America Leu-Enkephalin Revenue by Application (2017-2028)
10.3 Latin America Leu-Enkephalin Sales by Country
10.3.1 Latin America Leu-Enkephalin Sales by Country (2017-2028)
10.3.2 Latin America Leu-Enkephalin Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Leu-Enkephalin Market Size by Purity
11.1.1 Middle East and Africa Leu-Enkephalin Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Leu-Enkephalin Revenue by Purity (2017-2028)
11.2 Middle East and Africa Leu-Enkephalin Market Size by Application
11.2.1 Middle East and Africa Leu-Enkephalin Sales by Application (2017-2028)
11.2.2 Middle East and Africa Leu-Enkephalin Revenue by Application (2017-2028)
11.3 Middle East and Africa Leu-Enkephalin Sales by Country
11.3.1 Middle East and Africa Leu-Enkephalin Sales by Country (2017-2028)
11.3.2 Middle East and Africa Leu-Enkephalin Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Peptide Institute
12.1.1 Peptide Institute Corporation Information
12.1.2 Peptide Institute Overview
12.1.3 Peptide Institute Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Peptide Institute Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Peptide Institute Recent Developments
12.2 Waters Corporation
12.2.1 Waters Corporation Corporation Information
12.2.2 Waters Corporation Overview
12.2.3 Waters Corporation Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Waters Corporation Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Waters Corporation Recent Developments
12.3 Tocris Bioscience
12.3.1 Tocris Bioscience Corporation Information
12.3.2 Tocris Bioscience Overview
12.3.3 Tocris Bioscience Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Tocris Bioscience Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Tocris Bioscience Recent Developments
12.4 Aapptec
12.4.1 Aapptec Corporation Information
12.4.2 Aapptec Overview
12.4.3 Aapptec Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Aapptec Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Aapptec Recent Developments
12.5 Phoenix Pharmaceuticals
12.5.1 Phoenix Pharmaceuticals Corporation Information
12.5.2 Phoenix Pharmaceuticals Overview
12.5.3 Phoenix Pharmaceuticals Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Phoenix Pharmaceuticals Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Phoenix Pharmaceuticals Recent Developments
12.6 MediMabs
12.6.1 MediMabs Corporation Information
12.6.2 MediMabs Overview
12.6.3 MediMabs Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 MediMabs Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 MediMabs Recent Developments
12.7 LifeTein
12.7.1 LifeTein Corporation Information
12.7.2 LifeTein Overview
12.7.3 LifeTein Leu-Enkephalin Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 LifeTein Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 LifeTein Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Leu-Enkephalin Industry Chain Analysis
13.2 Leu-Enkephalin Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Leu-Enkephalin Production Mode & Process
13.4 Leu-Enkephalin Sales and Marketing
13.4.1 Leu-Enkephalin Sales Channels
13.4.2 Leu-Enkephalin Distributors
13.5 Leu-Enkephalin Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Leu-Enkephalin Industry Trends
14.2 Leu-Enkephalin Market Drivers
14.3 Leu-Enkephalin Market Challenges
14.4 Leu-Enkephalin Market Restraints
15 Key Finding in The Global Leu-Enkephalin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Leu-Enkephalin Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.95
Table 3. Major Manufacturers of 0.99
Table 4. Global Leu-Enkephalin Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Leu-Enkephalin Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Leu-Enkephalin Production by Region (2017-2022) & (Tons)
Table 7. Global Leu-Enkephalin Production Market Share by Region (2017-2022)
Table 8. Global Leu-Enkephalin Production by Region (2023-2028) & (Tons)
Table 9. Global Leu-Enkephalin Production Market Share by Region (2023-2028)
Table 10. Global Leu-Enkephalin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Leu-Enkephalin Sales by Region (2017-2022) & (Tons)
Table 12. Global Leu-Enkephalin Sales Market Share by Region (2017-2022)
Table 13. Global Leu-Enkephalin Sales by Region (2023-2028) & (Tons)
Table 14. Global Leu-Enkephalin Sales Market Share by Region (2023-2028)
Table 15. Global Leu-Enkephalin Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Leu-Enkephalin Revenue Market Share by Region (2017-2022)
Table 17. Global Leu-Enkephalin Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Leu-Enkephalin Revenue Market Share by Region (2023-2028)
Table 19. Global Leu-Enkephalin Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Leu-Enkephalin Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Leu-Enkephalin Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Leu-Enkephalin Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Leu-Enkephalin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Leu-Enkephalin Revenue Share by Manufacturers (2017-2022)
Table 25. Leu-Enkephalin Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Leu-Enkephalin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Leu-Enkephalin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leu-Enkephalin as of 2021)
Table 28. Leu-Enkephalin Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Leu-Enkephalin Product Offered
Table 30. Date of Manufacturers Enter into Leu-Enkephalin Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Leu-Enkephalin Sales by Purity (2017-2022) & (Tons)
Table 33. Global Leu-Enkephalin Sales by Purity (2023-2028) & (Tons)
Table 34. Global Leu-Enkephalin Sales Share by Purity (2017-2022)
Table 35. Global Leu-Enkephalin Sales Share by Purity (2023-2028)
Table 36. Global Leu-Enkephalin Revenue by Purity (2017-2022) & (US$ Million)
Table 37. Global Leu-Enkephalin Revenue by Purity (2023-2028) & (US$ Million)
Table 38. Global Leu-Enkephalin Revenue Share by Purity (2017-2022)
Table 39. Global Leu-Enkephalin Revenue Share by Purity (2023-2028)
Table 40. Leu-Enkephalin Price by Purity (2017-2022) & (US$/Ton)
Table 41. Global Leu-Enkephalin Price Forecast by Purity (2023-2028) & (US$/Ton)
Table 42. Global Leu-Enkephalin Sales by Application (2017-2022) & (Tons)
Table 43. Global Leu-Enkephalin Sales by Application (2023-2028) & (Tons)
Table 44. Global Leu-Enkephalin Sales Share by Application (2017-2022)
Table 45. Global Leu-Enkephalin Sales Share by Application (2023-2028)
Table 46. Global Leu-Enkephalin Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Leu-Enkephalin Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Leu-Enkephalin Revenue Share by Application (2017-2022)
Table 49. Global Leu-Enkephalin Revenue Share by Application (2023-2028)
Table 50. Leu-Enkephalin Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Leu-Enkephalin Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Leu-Enkephalin Sales by Purity (2017-2022) & (Tons)
Table 53. North America Leu-Enkephalin Sales by Purity (2023-2028) & (Tons)
Table 54. North America Leu-Enkephalin Revenue by Purity (2017-2022) & (US$ Million)
Table 55. North America Leu-Enkephalin Revenue by Purity (2023-2028) & (US$ Million)
Table 56. North America Leu-Enkephalin Sales by Application (2017-2022) & (Tons)
Table 57. North America Leu-Enkephalin Sales by Application (2023-2028) & (Tons)
Table 58. North America Leu-Enkephalin Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Leu-Enkephalin Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Leu-Enkephalin Sales by Country (2017-2022) & (Tons)
Table 61. North America Leu-Enkephalin Sales by Country (2023-2028) & (Tons)
Table 62. North America Leu-Enkephalin Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Leu-Enkephalin Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Leu-Enkephalin Sales by Purity (2017-2022) & (Tons)
Table 65. Europe Leu-Enkephalin Sales by Purity (2023-2028) & (Tons)
Table 66. Europe Leu-Enkephalin Revenue by Purity (2017-2022) & (US$ Million)
Table 67. Europe Leu-Enkephalin Revenue by Purity (2023-2028) & (US$ Million)
Table 68. Europe Leu-Enkephalin Sales by Application (2017-2022) & (Tons)
Table 69. Europe Leu-Enkephalin Sales by Application (2023-2028) & (Tons)
Table 70. Europe Leu-Enkephalin Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Leu-Enkephalin Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Leu-Enkephalin Sales by Country (2017-2022) & (Tons)
Table 73. Europe Leu-Enkephalin Sales by Country (2023-2028) & (Tons)
Table 74. Europe Leu-Enkephalin Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Leu-Enkephalin Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Leu-Enkephalin Sales by Purity (2017-2022) & (Tons)
Table 77. Asia Pacific Leu-Enkephalin Sales by Purity (2023-2028) & (Tons)
Table 78. Asia Pacific Leu-Enkephalin Revenue by Purity (2017-2022) & (US$ Million)
Table 79. Asia Pacific Leu-Enkephalin Revenue by Purity (2023-2028) & (US$ Million)
Table 80. Asia Pacific Leu-Enkephalin Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Leu-Enkephalin Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Leu-Enkephalin Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Leu-Enkephalin Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Leu-Enkephalin Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Leu-Enkephalin Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Leu-Enkephalin Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Leu-Enkephalin Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Leu-Enkephalin Sales by Purity (2017-2022) & (Tons)
Table 89. Latin America Leu-Enkephalin Sales by Purity (2023-2028) & (Tons)
Table 90. Latin America Leu-Enkephalin Revenue by Purity (2017-2022) & (US$ Million)
Table 91. Latin America Leu-Enkephalin Revenue by Purity (2023-2028) & (US$ Million)
Table 92. Latin America Leu-Enkephalin Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Leu-Enkephalin Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Leu-Enkephalin Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Leu-Enkephalin Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Leu-Enkephalin Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Leu-Enkephalin Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Leu-Enkephalin Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Leu-Enkephalin Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Leu-Enkephalin Sales by Purity (2017-2022) & (Tons)
Table 101. Middle East and Africa Leu-Enkephalin Sales by Purity (2023-2028) & (Tons)
Table 102. Middle East and Africa Leu-Enkephalin Revenue by Purity (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Leu-Enkephalin Revenue by Purity (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Leu-Enkephalin Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Leu-Enkephalin Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Leu-Enkephalin Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Leu-Enkephalin Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Leu-Enkephalin Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Leu-Enkephalin Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Leu-Enkephalin Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Leu-Enkephalin Revenue by Country (2023-2028) & (US$ Million)
Table 112. Peptide Institute Corporation Information
Table 113. Peptide Institute Description and Major Businesses
Table 114. Peptide Institute Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Peptide Institute Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Peptide Institute Recent Development
Table 117. Waters Corporation Corporation Information
Table 118. Waters Corporation Description and Major Businesses
Table 119. Waters Corporation Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Waters Corporation Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Waters Corporation Recent Development
Table 122. Tocris Bioscience Corporation Information
Table 123. Tocris Bioscience Description and Major Businesses
Table 124. Tocris Bioscience Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Tocris Bioscience Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Tocris Bioscience Recent Development
Table 127. Aapptec Corporation Information
Table 128. Aapptec Description and Major Businesses
Table 129. Aapptec Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Aapptec Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Aapptec Recent Development
Table 132. Phoenix Pharmaceuticals Corporation Information
Table 133. Phoenix Pharmaceuticals Description and Major Businesses
Table 134. Phoenix Pharmaceuticals Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Phoenix Pharmaceuticals Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Phoenix Pharmaceuticals Recent Development
Table 137. MediMabs Corporation Information
Table 138. MediMabs Description and Major Businesses
Table 139. MediMabs Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. MediMabs Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. MediMabs Recent Development
Table 142. LifeTein Corporation Information
Table 143. LifeTein Description and Major Businesses
Table 144. LifeTein Leu-Enkephalin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. LifeTein Leu-Enkephalin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. LifeTein Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Leu-Enkephalin Distributors List
Table 150. Leu-Enkephalin Customers List
Table 151. Leu-Enkephalin Market Trends
Table 152. Leu-Enkephalin Market Drivers
Table 153. Leu-Enkephalin Market Challenges
Table 154. Leu-Enkephalin Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Leu-Enkephalin Product Picture
Figure 2. Global Leu-Enkephalin Market Share by Purity in 2021 & 2028
Figure 3. 0.95 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. Global Leu-Enkephalin Market Share by Application in 2021 & 2028
Figure 6. Scientific Research
Figure 7. Medical
Figure 8. Others
Figure 9. Leu-Enkephalin Report Years Considered
Figure 10. Global Leu-Enkephalin Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Leu-Enkephalin Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Leu-Enkephalin Production Market Share by Region (2017-2022)
Figure 13. Global Leu-Enkephalin Production Market Share by Region (2023-2028)
Figure 14. Leu-Enkephalin Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Leu-Enkephalin Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Leu-Enkephalin Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Leu-Enkephalin Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 18. Global Leu-Enkephalin Sales 2017-2028 (Tons)
Figure 19. Global Leu-Enkephalin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Leu-Enkephalin Revenue 2017-2028 (US$ Million)
Figure 21. Global Leu-Enkephalin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Leu-Enkephalin Sales Market Share by Region (2017-2022)
Figure 23. Global Leu-Enkephalin Sales Market Share by Region (2023-2028)
Figure 24. North America Leu-Enkephalin Sales YoY (2017-2028) & (Tons)
Figure 25. North America Leu-Enkephalin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Leu-Enkephalin Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Leu-Enkephalin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Leu-Enkephalin Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Leu-Enkephalin Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Leu-Enkephalin Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Leu-Enkephalin Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Leu-Enkephalin Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Leu-Enkephalin Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Leu-Enkephalin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Leu-Enkephalin in the World: Market Share by Leu-Enkephalin Revenue in 2021
Figure 36. Leu-Enkephalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Leu-Enkephalin Sales Market Share by Purity (2017-2028)
Figure 38. Global Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
Figure 39. Global Leu-Enkephalin Sales Market Share by Application (2017-2028)
Figure 40. Global Leu-Enkephalin Revenue Market Share by Application (2017-2028)
Figure 41. North America Leu-Enkephalin Sales Market Share by Purity (2017-2028)
Figure 42. North America Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
Figure 43. North America Leu-Enkephalin Sales Market Share by Application (2017-2028)
Figure 44. North America Leu-Enkephalin Revenue Market Share by Application (2017-2028)
Figure 45. North America Leu-Enkephalin Sales Share by Country (2017-2028)
Figure 46. North America Leu-Enkephalin Revenue Share by Country (2017-2028)
Figure 47. United States Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Leu-Enkephalin Sales Market Share by Purity (2017-2028)
Figure 50. Europe Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
Figure 51. Europe Leu-Enkephalin Sales Market Share by Application (2017-2028)
Figure 52. Europe Leu-Enkephalin Revenue Market Share by Application (2017-2028)
Figure 53. Europe Leu-Enkephalin Sales Share by Country (2017-2028)
Figure 54. Europe Leu-Enkephalin Revenue Share by Country (2017-2028)
Figure 55. Germany Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 56. France Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Leu-Enkephalin Sales Market Share by Purity (2017-2028)
Figure 61. Asia Pacific Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
Figure 62. Asia Pacific Leu-Enkephalin Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Leu-Enkephalin Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Leu-Enkephalin Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Leu-Enkephalin Revenue Share by Region (2017-2028)
Figure 66. China Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 69. India Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Leu-Enkephalin Sales Market Share by Purity (2017-2028)
Figure 76. Latin America Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
Figure 77. Latin America Leu-Enkephalin Sales Market Share by Application (2017-2028)
Figure 78. Latin America Leu-Enkephalin Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Leu-Enkephalin Sales Share by Country (2017-2028)
Figure 80. Latin America Leu-Enkephalin Revenue Share by Country (2017-2028)
Figure 81. Mexico Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Leu-Enkephalin Sales Market Share by Purity (2017-2028)
Figure 85. Middle East and Africa Leu-Enkephalin Revenue Market Share by Purity (2017-2028)
Figure 86. Middle East and Africa Leu-Enkephalin Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Leu-Enkephalin Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Leu-Enkephalin Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Leu-Enkephalin Revenue Share by Country (2017-2028)
Figure 90. Turkey Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Leu-Enkephalin Revenue (2017-2028) & (US$ Million)
Figure 93. Leu-Enkephalin Value Chain
Figure 94. Leu-Enkephalin Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed